Top compounds associated with response to FBXL18


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.11 0.0006
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA A-770041 GDSC1000 pan-cancer AAC 0.17 0.0008
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.1 0.001
mRNA lapatinib gCSI pan-cancer AAC 0.2 0.001
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.11 0.001
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.13 0.001
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.25 0.002
mRNA PD318088 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV